Brief #51683Updated 18 JUN 2026LOS ALTOSMEDICAL ORGANIZATIONSPOST IPO EQUITY
Employbl DossierRenovoRx
RenovoRx has developed RenovoCath™, a dual-balloon infusion catheter, for targeted chemotherapy delivery for pancreatic cancer patients.
- Founded
- 2012
- Headcount
- 26
- Open roles
- 0
- Last raised
- Post Ipo Equity · $10M
Section II · Premium ProfileMembers only
- 01Engineering interview process at RenovoRxLocked
- 02Tech stack & infrastructure choicesLocked
- 03Culture & day-to-day work styleLocked
- 04Why join now vs. 6 months from nowLocked
- 05Hiring focus & open headcount by teamLocked
- 06Comp philosophy and band contextLocked
7-day free trial · $25/mo · cancel anytime
